Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
BeiGene Ltd ( (HK:6160) ) has issued an announcement.
BeiGene Ltd., a biopharmaceutical company, announced the grant of share options and restricted share units under its 2016 Share Option and Incentive Plan. The company allocated 9,073 American Depositary Shares (ADSs) in options to five grantees and 99,670 ADSs in restricted share units to 275 grantees. This move is part of BeiGene’s strategy to incentivize and retain talent, potentially strengthening its operational capabilities and market position.
More about BeiGene Ltd
YTD Price Performance: 26.56%
Average Trading Volume: 1,829,741
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$199.1B
For a thorough assessment of 6160 stock, go to TipRanks’ Stock Analysis page.
